Your browser doesn't support javascript.
loading
Metabolism and excretion of (S)-6-(3-cyclopentyl-2-(4-trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid (PF-04991532), a hepatoselective glucokinase activator, in humans: confirmation of the MIST potential noted in first-in-Human metabolite scouting studies.
Sharma, Raman; Bergman, Arthur; Litchfield, John; Atkinson, Karen; Kazierad, David J; Kalgutkar, Amit S.
Afiliación
  • Sharma R; Medicine Design Pfizer Worldwide Research and Development , Groton , CT , USA.
  • Bergman A; Clinical Pharmacology/Pharmacometrics Pfizer Worldwide Research and Development , Groton , CT , USA.
  • Litchfield J; Medicine Design Pfizer Worldwide Research and Development , Cambridge , MA , USA.
  • Atkinson K; Medicine Design Pfizer Worldwide Research and Development , Groton , CT , USA.
  • Kazierad DJ; Clinical Sciences Pfizer Worldwide Research and Development , Cambridge , MA , USA.
  • Kalgutkar AS; Medicine Design Pfizer Worldwide Research and Development , Cambridge , MA , USA.
Xenobiotica ; 49(12): 1447-1457, 2019 Dec.
Article en En | MEDLINE | ID: mdl-30747552

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Imidazoles / Ácidos Nicotínicos Límite: Adolescent / Adult / Animals / Humans / Male / Middle aged Idioma: En Revista: Xenobiotica Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Imidazoles / Ácidos Nicotínicos Límite: Adolescent / Adult / Animals / Humans / Male / Middle aged Idioma: En Revista: Xenobiotica Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos